A5056947295- Bariatric Surgery and Outcomes
- Esophageal and GI Pathology
- Body Contouring and Surgery
- Diet and metabolism studies
- Gastric Cancer Management and Outcomes
- Gastroesophageal reflux and treatments
- Obesity and Health Practices
- Diabetes Treatment and Management
- Gastrointestinal disorders and treatments
- Esophageal Cancer Research and Treatment
- Minimally Invasive Surgical Techniques
- Gallbladder and Bile Duct Disorders
- Dysphagia Assessment and Management
- Pharmacology and Obesity Treatment
- Gastrointestinal motility and disorders
- Helicobacter pylori-related gastroenterology studies
- Cardiac, Anesthesia and Surgical Outcomes
- Gastrointestinal Tumor Research and Treatment
- Cardiovascular Function and Risk Factors
- Liver Disease Diagnosis and Treatment
- Intestinal and Peritoneal Adhesions
- Eosinophilic Esophagitis
- Clinical Nutrition and Gastroenterology
- Intestinal Malrotation and Obstruction Disorders
- Surgical Simulation and Training
Faculdade de Medicina do ABC
2015-2024
Indo Korea Science and Technology
2023-2024
Oregon Weight Loss Surgery
2024
Orlando Health
2024
Sri Aurobindo Institute of Technology
2023-2024
Orlando Regional Medical Center
2024
Hospital Universitario Dexeus
2020-2023
Hospital Universitario 12 De Octubre
2023
Hospital Son Llatzer
2023
Aurobindo Pharma (India)
2022-2023
OBJECTIVE To assess procedural safety and glycemic indices at 6 months in a first-in-human study of duodenal mucosal resurfacing (DMR), novel, minimally invasive, upper endoscopic procedure involving hydrothermal ablation the mucosa, patients with type 2 diabetes HbA1c ≥7.5% (58 mmol/mol) on one or more oral antidiabetic agents. RESEARCH DESIGN AND METHODS Using novel balloon catheters, DMR was conducted varying lengths duodenum anesthetized single medical center. RESULTS A total 39...
The duodenum has become a metabolic treatment target through bariatric surgery learnings and the specific observation that bypassing, excluding or altering duodenal nutrient exposure elicits favourable changes. Duodenal mucosal resurfacing (DMR) is novel endoscopic procedure been shown to improve glycaemic control in people with type 2 diabetes mellitus (T2D) irrespective of body mass index (BMI) DMR involves catheter-based circumferential lifting followed by hydrothermal ablation mucosa....
Objectives: Natural orifice translumenal endoscopic surgery (NOTES) is evolving as a promising alternative for abdominal surgery. IMTN Registry was designed to prospectively document early results of natural among large group clinical cases. Methods: Sixteen centers from 9 countries were approved participate in the study, based on study protocol requirements and local institutional review board approval. Transgastric transvaginal clinically applied 362 patients. Intraoperative postoperative...
The purpose of this study was to evaluate the effect duodenal-jejunal bypass liner (DJBL), a 60-cm, impermeable fluoropolymer anchored in duodenum create bypass, on metabolic parameters obese subjects with type 2 diabetes.Twenty-two (mean age, 46.2±10.5 years) diabetes and body mass index between 40 60 kg/m(2) index, 44.8±7.4 kg/m(2)) were enrolled 52-week, prospective, open-label clinical trial. Endoscopic device implantation performed patient under general anesthesia, examined periodically...
Bariatric endoscopy has emerged as an aid in the nonsurgical treatment of obesity. The objective this study is to critically provide results and follow-up endoscopic sleeve gastroplasty 1 year after procedure.Prospective single-center 25 patients (5 men, 20 women) who underwent flexible suturing for endoluminal gastric volume reduction. A multidisciplinary team provided post-procedure care. Patient outcomes were recorded at procedure. Linear regression analysis was done evaluate variables...
Hydrothermal duodenal mucosal resurfacing (DMR) is a safe, outpatient endoscopic procedure. REVITA-2, double-blind, superiority randomised controlled trial, investigates safety and efficacy of DMR using the single catheter Revita system (Revita (catheter system)), on glycaemic control liver fat content in type 2 diabetes (T2D).Eligible patients (haemoglobin A1c (HbA1c) 59-86 mmol/mol, body mass index≥24 ≤40 kg/m2, fasting insulin >48.6 pmol/L, ≥1 oral antidiabetic medication) enrolled Europe...
Abstract The use of digital technology is increasing rapidly across surgical specialities, yet there no consensus for the term ‘digital surgery’. This critical as health technologies present technical, governance, and legal challenges which are unique to surgeon patient. We aim define surgery ethical issues surrounding its clinical application, identify barriers research goals future practice. 38 international experts, fields surgery, AI, industry, law, ethics policy, participated in a...
Abstract Metabolic and bariatric surgery (MBS) is widely considered the most effective option for treating obesity, a chronic, relapsing, progressive disease. Recently, American Society of Bariatric Surgery (ASMBS) International Federation Obesity Disorders (IFSO) issued new guidelines on indications MBS, which have superseded previous 1991 National Institutes Health guidelines. The aim this study to establish first set consensus selecting procedures in Class I II using an Expert Modified...
Background: Bariatric surgery is associated with the rapid improvement of type 2 diabetes (T2DM). Here we report an exploratory trial a completely endoscopic, removable, duodenal-jejunal bypass liner (DJBL) intended to treat T2DM. Methods: Obese T2DM subjects were randomized receive DJBL (n = 12) or sham endoscopy 6) in 24-week study, extended up 52 weeks. Measurements included weights, hemoglobin A1c (HbA1c), meal tolerance testing, fasting glucose, and seven-point glucose profiles....
Zundel, Natan MD, FACS; Hernandez, Juan D. MD; Neto, Manoel Galvao Campos, Josemberg MD Author Information